South Dakota § 34-20B-28.1 Definition of terms applicable to code imprinted drugs.

South Dakota Statutes

§ 34-20B-28.1 — Definition of terms applicable to code imprinted drugs.

South Dakota § 34-20B-28.1

Title 34PUBLIC HEALTH AND SAFETY

Ch. 34-20DRUGS AND SUBSTANCES CONTROL

This text of South Dakota § 34-20B-28.1 (Definition of terms applicable to code imprinted drugs.) is published on Counsel Stack Legal Research, covering South Dakota primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

S.D. Codified Laws § 34-20B-28.1 (2026).

Text

Terms used in §§ 34-20B-28.2 to 34-20B-28.6 , inclusive, unless the context plainly otherwise requires, mean:

(1)"Code imprint," a series of letters or numbers assigned by the manufacturer or distributor to a specific drug, or marks or monograms unique to the manufacturer or distributor of the drug, or both;

(2)"Distributor," a person who distributes for resale a drug in solid dosage form under his own label even though he is not the actual manufacturer of the drug;

(3)"Legend drug," any drug defined by section 503(b) of the Federal Food, Drug and Cosmetic Act, as amended on January 15, 1980, and under which definition its label is required to bear the statement "Caution: Federal law prohibits dispensing without prescription";

(4)"Solid dosage form," capsules or tablets int

Free access — add to your briefcase to read the full text and ask questions with AI

Terms used in §§ 34-20B-28.2 to 34-20B-28.6 , inclusive, unless the context plainly otherwise requires, mean: (1) "Code imprint," a series of letters or numbers assigned by the manufacturer or distributor to a specific drug, or marks or monograms unique to the manufacturer or distributor of the drug, or both; (2) "Distributor," a person who distributes for resale a drug in solid dosage form under his own label even though he is not the actual manufacturer of the drug; (3) "Legend drug," any drug defined by section 503(b) of the Federal Food, Drug and Cosmetic Act, as amended on January 15, 1980, and under which definition its label is required to bear the statement "Caution: Federal law prohibits dispensing without prescription"; (4) "Solid dosage form," capsules or tablets intended for oral use.